Daiwa Securities Group Inc. Kezar Life Sciences, Inc. Transaction History

Daiwa Securities Group Inc.

  • $29.6 Billion
  • Q3 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 06, 2023
BUY
$6.39 - $8.8 $817 - $1,126
128 Added 87.07%
275 $2,000
Q1 2022

Apr 29, 2022
BUY
$12.3 - $18.33 $738 - $1,099
60 Added 68.97%
147 $2,000
Q4 2020

Feb 04, 2021
BUY
$4.77 - $6.58 $414 - $572
87 New
87 $0

Others Institutions Holding KZR

# of Institutions
3
Shares Held
1.54M
Call Options Held
0
Put Options Held
0
View Full List

About Kezar Life Sciences, Inc.

KZR Quotes by TradingView
  • Ticker KZR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,369,504
  • Market Cap $423M
  • Description
  • Kezar Life Sciences, Inc., a clinical-stage biotechnology company, engages in the discovery and development of novel small molecule therapeutics to treat unmet needs in immune-mediated diseases and cancer in the United States. The company's lead product candidate is KZR-616, a selective immunoproteasome inhibitor that is in Phase 2 clinical tria...
More about KZR
Track This Portfolio

Track Daiwa Securities Group Inc. Portfolio

Follow Daiwa Securities Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Daiwa Securities Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Daiwa Securities Group Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email